Skip to main content

Icon Legend
Presentation Icons
Event Add-on
Event Add-on
In Person Only
In Person Only
Off-site Event
Off-site Event
Location: Marriott Marquis
Location: Marriott Marquis

Abstracts

Abstracts

  • Sunday, September 29, 2024
  • 8:00 AM - 8:10 AM ET
    100 - Primary Outcome Analysis for Shortening Adjuvant Photon Irradiation to Reduce Edema (SAPHIRE): A Randomized, Phase III Trial of Hypo- vs. Conventionally Fractionated Regional Nodal Irradiation (RNI)
    Location: Room 202
    Presenter: Karen Hoffman, MD, FASTRO – MD Anderson Cancer Center
  • 8:10 AM - 8:20 AM ET
    101 - Long Term Rates of Lymphedema in Hypofractionated Nodal Regional Irradiation for Women with Breast Cancer: A Phase 2 Clinical Trial - "HeNRIetta"
    Location: Room 202
    Presenter: Alfredo Urdaneta, MD – Virginia Commonwealth University Health System
  • 8:20 AM - 8:30 AM ET
    102 - NOVEMBER, A Phase II Trial of a 9 Day Course of Whole Breast Radiotherapy for Early Stage Breast Cancer
    Location: Room 202
    Presenter: Matthew Poppe, MD, FASTRO – University of Utah Huntsman Cancer Institute
  • 8:30 AM - 8:40 AM ET
    103 - Early Safety of Ultra-Hypofractionated Whole Breast Irradiation and Sequential Tumor Bed Boost for Early Breast Cancer (SHIFT): A Multicenter, Phase 2 Trial
    Location: Room 202
    Presenter: Siyue Zheng, MD – Ruijin Hospital, Shanghai Jiaotong University School of Medicine
  • 8:40 AM - 8:50 AM ET
    104 - Conventional vs. Hypofractionated Proton Postmastectomy Radiotherapy: Patient Reported Outcomes from a Randomized Phase 2 Trial
    Location: Room 202
    Presenter: Muhammad Shuja, MD – Mayo Clinic Rochester
  • 8:50 AM - 9:00 AM ET
    Discussant
    Location: Room 202
    Discussant: Asal Rahimi, MD, MS – University of Texas Southwestern Medical Center
  • 8:00 AM - 8:10 AM ET
    105 - Phase I Clinical Trial of Lobaplatin Combined with Image-Guided Volume-Modulated Arc Radiation Therapy in Locally Advanced Cervical Cancer
    Location: Room 204
    Presenter: Jing You, MD
  • 8:10 AM - 8:20 AM ET
    106 - Early Assessment of Response Using ctDNA as a Non-Invasive Biomarker in Patients with Gynecologic Malignancies Undergoing Radiotherapy
    Location: Room 204
    Presenter: Gabriella Wernicke, MD, MS – Northwell Health Cancer Institute
  • 8:20 AM - 8:30 AM ET
    107 - Moderated Hypofractionated Online Adaptive Radiotherapy in Locally Advanced Cervical Cancer: A Prospective 1 Clinical Trial
    Location: Room 204
    Presenter: Zheng Zeng, MD – Peking Union Medical College Hospital
  • 8:30 AM - 8:40 AM ET
    108 - Acceleration of Overall Treatment Time by Mono-Application Multifractionated Brachytherapy over 48 Hours vs. Sequential Weekly Application Brachytherapy in Carcinoma Cervix - Multi-Institutional, Subc
    Location: Room 204
    Presenter: Krithikaa Sekar, MD, MBBS – Healthcare Global Enterprises Ltd.
  • 8:40 AM - 8:50 AM ET
    109 - Image Guided Brachytherapy Quality Assurance on NRG GY017, an NRG Oncology Clinical Trial Investigating the Sequencing of Immunotherapy and Chemoradiation for Locally Advanced Cervical Cancer
    Location: Room 204
    Presenter: Hayeon Kim, PhD – Magee Womens Hospital of University of Pittsburgh Medical Center and Hillman Cancer Center
  • 8:50 AM - 9:00 AM ET
    Discussant
    Location: Room 204
    Discussant: Scott Glaser, MD – City of Hope National Medical Center
  • 8:00 AM - 8:10 AM ET
    110 - Clinical Outcomes for Standard of Care Machine Learning Prostate Radiotherapy Treatment Planning
    Location: Room 147
    Presenter: Jeff Winter, PhD – University Health Network
  • 8:10 AM - 8:20 AM ET
    111 - DeepTuning: A Novel Deep Learning Approach for Interactive Plan Tuning and Trade-Off Exploration
    Location: Room 147
    Presenter: Lin Ma, PhD – Mayo Clinic College of Medicine and Science Rochester
  • 8:20 AM - 8:30 AM ET
    112 - Initial Clinical Experience of Cherenkov Imaging in Sub-Total Total Skin Electron Therapy Identifies Opportunities to Improve Daily Set-Up QA
    Location: Room 147
    Presenter: Brook Byrd, PhD, MS, BS – Penn Medicine Radiation Oncology Abramson Cancer Center
  • 8:30 AM - 8:40 AM ET
    113 - Individual Radiotherapy Plan Based on Multi-Omics Model Study for Cervical Cancer Patients with Ovarian Preservation
    Location: Room 147
    Presenter: Guang Li, PhD – Chongqing University Cancer Hospital
  • 8:40 AM - 8:50 AM ET
    114 - Results of a Dose Reconstruction Effort for a Large-Scale Retrospective Study on Late Health Effects Following Radiotherapy within the National Wilms Tumor Study
    Location: Room 147
    Presenter: Matthew Mille, PhD – National Cancer Institute
  • 8:50 AM - 9:00 AM ET
    115 - Multi-Institutional Standardized Dosimetry Protocol for Preclinical Radiobiological Experiments
    Location: Room 147
    Presenter: Stavros Melemenidis, PhD – Stanford University
  • 8:00 AM - 8:05 AM ET
    Introduction
    Location: Room 207 B
  • 8:05 AM - 8:10 AM ET
    1000 - Impact of Prior Local Therapy (LT) on Treatment Response and Survival of Men with Metastatic Castrate Resistant Prostate Cancer (mCRPC): A Pooled Analysis of COU-AA-302 and ACIS Trials
    Location: Room 207 B
    Presenter: Omar Azem, MD – Rush University Medical Center
  • 8:10 AM - 8:15 AM ET
    1001 - Post-Prostatectomy Linac-Based Ultrahypofractionated Radiotherapy for Patients with Localized Prostate Cancer: Toxicity and Quality-of Life Results from a Prospective Trial
    Location: Room 207 B
    Presenter: Chia-Lin Tseng, MD – Sunnybrook Health Sciences Centre
  • 8:15 AM - 8:20 AM ET
    1002 - Radiotherapy of the Primary Tumor and All Metastatic Lesions in Oligometastatic Prostate Cancer: 5-Year Results of Prolong Study
    Location: Room 207 B
    Presenter: Xin Qi, MD, MS – Peking University First Hospital
  • 8:20 AM - 8:25 AM ET
    1003 - Initial Results of a Phase 2 Trial of Stereotactic Body Radiation Therapy, Hormone/Androgen Deprivation Therapy and Radium 223 Dichloride for Oligometastatic Castrate Sensitive Prostate Cancer (SHARP)
    Location: Room 207 B
    Presenter: Savita Dandapani, MD, PhD – City of Hope Comprehensive Cancer Center
  • 8:25 AM - 8:30 AM ET
    1004 - Stereotactic Body Radiation Therapy (SBRT) Combined with Pelvic Radiotherapy and GTV Boost Based on Multiparameter Magnetic Resonance Image for High-Risk Prostate Cancer: A Phase II Study
    Location: Room 207 B
    Presenter: Ouying Yan
  • 8:30 AM - 8:35 AM ET
    1005 - A Prospective Pilot Study Investigating 18F rhPSMA-7.3 PET/MRI to Detect Recurrent Disease and Guide Radiotherapy Planning in Patients with Biochemically Recurrent Prostate Cancer Post-Pros
    Location: Room 207 B
    Presenter: Devaki Shilpa Surasi, MD – MD Anderson Cancer Center
  • 8:35 AM - 8:55 AM ET
    Questions and Answers
    Location: Room 207 B
  • 8:55 AM - 9:00 AM ET
    Closing
    Location: Room 207 B
  • 1:00 PM - 1:10 PM ET
    2 - A Prospective, Phase II Study of 177Lu-Dotatate in Patients with Surgery- and Radiation-Refractory Meningioma: Results of the WHO Grade II/III Cohort
    Location: Ballroom A/B/C
    Presenter: Kenneth Merrell, MD, MS – Mayo Clinic Alix School of Medicine
  • 1:10 PM - 1:20 PM ET
    3 - A Phase 3 Study of Pembrolizumab (Pembro) + Concurrent Chemoradiotherapy (CCRT) for High-Risk Locally Advanced Cervical Cancer (LACC): Safety Findings
    Location: Ballroom A/B/C
    Presenter: Gabriella Macchia, MD – Responsible Research Hospital
  • 1:20 PM - 1:30 PM ET
    4 - Hypofractionated Whole-Breast Irradiation with Simultaneous Integrated Boost for Breast Cancer: Primary Analysis of the HYPOSIB-Trial (ARO 2013-05)
    Location: Ballroom A/B/C
    Presenter: David Krug, MD – University Hospital Hamburg-Eppendorf
  • 1:30 PM - 1:40 PM ET
    Discussant
    Location: Ballroom A/B/C
    Discussant: Kimberly Corbin, MD – Mayo Clinic Alix School of Medicine
  • 1:40 PM - 1:50 PM ET
    5 - Pirfenidone in the Treatment of Radiation-Induced Lung Injury: A Randomized, Controlled, Multicenter Clinical Trial
    Location: Ballroom A/B/C
    Presenter: Ming Chen, MD – Sun Yat-Sen University Cancer Center
  • 1:50 PM - 2:00 PM ET
    LBA04 - Bladder Adjuvant RadioTherapy (BART): Acute and Late Toxicity from a Phase III Multicenter Randomized Controlled Trial
    Location: Ballroom A/B/C
    Presenter: Vedang Murthy, MD – Tata Memorial Centre
  • 2:00 PM - 2:10 PM ET
    LBA05 - MR-Linac On-Line Weekly Adaptive Radiotherapy for High Grade Glioma (HGG): Results from the UNITED Single Arm Phase II Trial
    Location: Ballroom A/B/C
    Presenter: Jay Detsky, MD, PhD – Sunnybrook Health Sciences Centre
  • 2:10 PM - 2:20 PM ET
    LBA06 - Short-Term Androgen Deprivation Therapy and High-Dose Radiotherapy in Intermediate- and High-Risk Localized Prostate Cancer: Results from the GETUG 14 Randomized Phase III Trial
    Location: Ballroom A/B/C
    Presenter: Nicolas Demogeot, MD – Institut de Cancerologie de Lorraine
  • 2:20 PM - 2:30 PM ET
    LBA07 - A Multicenter Phase III Randomized Clinical Trial Comparing the Efficacy of an Adjuvant SOX Chemotherapy Regimen with SOX Combined with a Simultaneous Radiotherapy Regimen after D2 Radical Resection f
    Location: Ballroom A/B/C
    Presenter: Ou-ying Yan, MD – Cancer Center, West China Hospital, Sichuan University
  • 2:45 PM - 2:55 PM ET
    130 - MORF4L1-Mediated DNA Damage Repair Modulates cGAS-STING Activation and Radiosensitivity in Hepatocellular Carcinoma
    Location: Room 152
    Presenter: Siwei Wang, PhD – Department of Radiation Oncology, Cancer Center, Zhongshan Hospital, Fudan University
  • 2:55 PM - 3:05 PM ET
    131 - Unraveling the Mechanism behind Prophylactic Radiotherapy to Prevent Traumatic Heterotopic Ossification
    Location: Room 152
    Presenter: Meng-Lun Hsieh, DO, PhD – University of Texas Southwestern Medical Center
  • 3:05 PM - 3:15 PM ET
    132 - SnoRNAs and Radiotherapy Resistance in Esophageal Squamous Cell Carcinoma
    Location: Room 152
  • 3:15 PM - 3:25 PM ET
    133 - The Impact of REXO4 Condensates on Irradiation-Induced Poly(ADP-ribosyl)ation and Tumor Radioresistance
    Location: Room 152
    Presenter: Xin-Juan Fan
  • 3:25 PM - 3:35 PM ET
    134 - O-GlcNAcylation of PRDX1 and Radiation Resistance in Non-Small Cell Lung Cancer via Suppressing TRIM21 Mediated Ubiquitination
    Location: Room 152
    Presenter: Ran Zhang, PhD – Shandong Cancer Hospital Affiliated to Shandong First Medical University
  • 3:35 PM - 3:45 PM ET
    135 - USP15 and Radiation-Induced DNA Damage Repair of Intestinal Epithelial Cells by Deubiquitinating and Stabilizing ATM
    Location: Room 152
    Presenter: Ruiqiu Zhu, MD, PhD – Soochow University
  • 2:45 PM - 2:50 PM ET
    Introduction
    Location: Room 158
  • 2:50 PM - 2:55 PM ET
    1006 - The Impact of an Outpatient Urgent Care Clinic in Patients Treated for Head and Neck Cancer
    Location: Room 158
    Presenter: Elliott Czarnecki, MD – Henry Ford Hospital
  • 2:55 PM - 3:00 PM ET
    1007 - Efficacy of Quantitative Targeted Exercise Combined with Full-Scale Refined Nutrition Management for Improving Nutrition in Patients with Head and Neck Cancer Receiving Radiotherapy - A Randomized Con
    Location: Room 158
    Presenter: Juanli Shi – Xijing Hospital Air Force Medical University
  • 3:00 PM - 3:05 PM ET
    1008 - The HEART Team Protocol: A Strategic Approach to High-Risk Patient Management in Adult Oncology to Reduce Emergency Room Visits and Hospital Admissions
    Location: Room 158
    Presenter: Yun Jeong Seo, DNP – Mount Sinai West
  • 3:05 PM - 3:10 PM ET
    1009 - Efficacy and Safety of a Dexamethasone-Free Antiemetic Regimen for Nausea and Emesis Prevention during Concurrent Chemoradiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC
    Location: Room 158
    Presenter: Ya Liu, MD
  • 3:10 PM - 3:15 PM ET
    1010 - Development of a Program Utilizing the Simple Measure of Gobbledygook (SMOG) Algorithm for Comprehending Patient-Generated Educational Content in the Field of Radiation Oncology
    Location: Room 158
    Presenter: Walter Chin, MS, BSN – Emory Clinic
  • 3:15 PM - 3:20 PM ET
    1011 - Education and Resource Needs of Financial Advocacy Staff Serving Radiation Oncology Patients
    Location: Room 158
    Presenter: Francinna Scott-Jones, CPAR, ROCC, FACCC – Northside Hospital
  • 3:20 PM - 3:40 PM ET
    Questions and Answers
    Location: Room 158
  • 3:40 PM - 3:45 PM ET
    Closing
    Location: Room 158
  • 2:45 PM - 2:55 PM ET
    136 - Examining the Impact of Combined P53 Status and PD-L1 Expression on Vulvar Cancer Outcomes
    Location: Room 207 B
    Presenter: Baher Elgohari, MD, MS, MBBS – UPMC Hillman Cancer Center
  • 2:55 PM - 3:05 PM ET
    137 - The Prognostic Impact of MLH1 Promoter Hypermethylation in Stage I-II Endometrial Cancer Treated with Adjuvant Radiotherapy
    Location: Room 207 B
    Presenter: Zohaib Sherwani, MD – Rutgers Cancer Institute of New Jersey
  • 3:05 PM - 3:15 PM ET
    138 - The Prognostic Value of Pretreatment Carbohydrate Antigen 125 Level in Cervical Cancer Patients Treated with Definitive Radiotherapy or Concurrent Chemoradiotherapy
    Location: Room 207 B
    Presenter: Dingchao Liu, MD – Peking Union Medical College Hospital
  • 3:15 PM - 3:25 PM ET
    139 - Longitudinal Dynamic MRI Radiomic Models for Early Prediction of Prognosis in Locally Advanced Cervical Cancer Treated with Concurrent Chemoradiotherapy
    Location: Room 207 B
    Presenter: Chang Cai, BS
  • 3:25 PM - 3:35 PM ET
    140 - Incidence of Cervical Cancer Subtypes in Relation to HPV Vaccination Uptake in the U.S.
    Location: Room 207 B
    Presenter: Peter Lee, MD, PhD – Fox Chase Cancer Center
  • 3:35 PM - 3:45 PM ET
    141 - Effect of Cisplatin Cycles on Prognosis for Locally Advanced Cervical Cancer Patients Treated with Concurrent Chemoradiotherapy: A Long-Term Follow-Up, Large Cohort Study
    Location: Room 207 B
    Presenter: Zheng Zeng, MD – Peking Union Medical College Hospital
  • 3:45 PM - 3:55 PM ET
    Discussant
    Location: Room 207 B
    Discussant: Eric Donnelly, MD – Northwestern Memorial Hospital
  • 2:45 PM - 2:55 PM ET
    123 - Efficacy of Kangfuxin Liquid Retention Enema in Preventing and Treating Radiation-Induced Proctitis in Cervical Cancer Patients: A Randomized, Open-Label, Phase III Study
    Location: Room 151
    Presenter: Xiaojing Yang, PhD – Shanghai Sixth People's Hospital
  • 2:55 PM - 3:05 PM ET
    124 - Evaluating Toxicity and Interaction Outcomes of Systemic Therapy and Stereotactic Ablative Radiotherapy for Oligometastatic Disease: A Secondary Analysis of the Phase II SABR-5 Trial
    Location: Room 151
    Presenter: Aiden Kooyman, BS – University of British Columbia
  • 3:05 PM - 3:15 PM ET
    125 - Impact of Clinical Target Volume Utilization on Outcomes in Patients with Non-Spine Bone Oligometastases Treated with Stereotactic Ablative Radiation Therapy
    Location: Room 151
    Presenter: Emily O'Reilly, MD, BS – BC Cancer - Vancouver Centre
  • 3:15 PM - 3:25 PM ET
    126 - Real-world implementation of simulation-free radiotherapy (SFRT-1000): A propensity score-matched analysis of 1000 consecutive palliative courses delivered in routine care
    Location: Room 151
    Presenter: Thilo Schuler, MD, MHInf – Northern Sydney Cancer Centre - Royal North Shore Hospital
  • 3:25 PM - 3:35 PM ET
    127 - Applying Deep Learning Based Facial Age Phenotyping to Improve Life Expectancy Prediction in Metastatic Cancer Patients Receiving Palliative Radiotherapy
    Location: Room 151
    Presenter: Grace Lee, MD – Harvard Radiation Oncology Program
  • 3:35 PM - 3:45 PM ET
    128 - Relationship between Cannabis Use and Opioid Use in Patients with Cancer Metastatic to Bone in a Large Multicenter Cohort from a State with Legalized Adult Non-Medical Cannabis
    Location: Room 151
    Presenter: Matthew Cousins, MD, PhD – Self Regional Healthcare
  • 3:45 PM - 3:55 PM ET
    129 - Time-Synchronized Immune-Guided Partial Tumor Irradiation: Proof-of-Principle Trial (NCT04168320)
    Location: Room 151
    Presenter: Slavisa Tubin, MD – MedAustron, Center for Ion Therapy and Research
  • 2:45 PM - 2:55 PM ET
    116 - Patient-Reported Functional Decline Following Active Surveillance (AS), Radical Prostatectomy (RP), External Beam Radiation without Androgen Deprivation Therapy (EBRT w/o ADT), or Low-Dose-Rate Brachy
    Location: Room 204
    Presenter: Patrick Carriere, MD, PhD – MD Anderson Cancer Center
  • 2:55 PM - 3:05 PM ET
    117 - A Prospective Interventional Clinical Trial (MC1732): Characterization of Thoracic Chemoradiotherapy-Related Cardiac Changes Using an Implantable Cardiac Monitor (ICM)
    Location: Room 204
    Presenter: Joshua Niska, MD – Mayo Clinic Arizona
  • 3:05 PM - 3:15 PM ET
    118 - Effectiveness of Nurse-Led Multimodal Rehabilitation for Patients Undergoing Postoperative Radiotherapy of Esophageal Cancer: A Randomized Controlled Trial
    Location: Room 204
    Presenter: Xianyan Chen, MD, PhD – West China Hospital of Sichuan University
  • 3:15 PM - 3:25 PM ET
    119 - From Face-to-Face to Digital Spaces: A Critical Look at Patient Satisfaction with Telehealth in Cancer Care
    Location: Room 204
    Presenter: Bailey Loving, MD – Beaumont Health - Royal Oak
  • 3:25 PM - 3:35 PM ET
    120 - Comparing Radiation and Systemic Therapy Patients Longitudinal Satisfaction of a Cloud-Based Bidirectional App Used for Real-Time Communication of Patient-Reported Cancer Treatment Symptoms
    Location: Room 204
    Presenter: Ian Kudel, PhD – Varian Medical Systems
  • 3:35 PM - 3:45 PM ET
    121 - Randomized Trial of Mindfulness during Radiation Therapy
    Location: Room 204
    Presenter: Elsa Sutton, MD – Mayo Clinic Rochester
  • 3:45 PM - 3:55 PM ET
    122 - Symptom Monitoring with Patient-Reported Outcomes during Definitive Radiation Treatment
    Location: Room 204
    Presenter: Ann Raldow, MD, MPH – UCLA Radiation Oncology
  • 4:45 PM - 4:55 PM ET
    148 - Proton Craniospinal Irradiation for Patients with Solid Tumor Leptomeningeal Metastasis- Final Analysis of a Phase II Study
    Location: Room 147
    Presenter: Jonathan Yang, MD, PhD – New York University School of Medicine
  • 4:55 PM - 5:05 PM ET
    149 - Risk of Radiation Myelitis after Hypofractionated Spine Stereotactic Body Radiation Therapy
    Location: Room 147
    Presenter: Christopher Jackson, MD, MS – Memorial Sloan Kettering Cancer Center
  • 5:05 PM - 5:15 PM ET
    150 - Evaluating Neurocognitive Recovery Following Stereotactic Radiosurgery and Whole Brain Radiation Therapy: Insights from a Pooled Analysis of Three Phase III Trials
    Location: Room 147
    Presenter: Hua-Ren Cherng, MD – University of Maryland Medical Center
  • 5:15 PM - 5:25 PM ET
    151 - Neurocognition and Quality of Life for Hypofractionated Stereotactic Radiotherapy (HFSRT) of the Resection Cavity vs. Whole-Brain Radiotherapy (WBRT) Following Brain Metastasis Resection - Results of
    Location: Room 147
    Presenter: Rami El Shafie, MD – University Medical Center Gottingen (UMG)
  • 5:25 PM - 5:35 PM ET
    152 - A Longitudinal Study to Correlate Neurocognitive Changes of IDH-Mutant and IDH-Wildtype Glioma Patients after Chemoradiotherapy with Changes on Resting-State MRI
    Location: Room 147
    Presenter: Zhihua Liu, PhD – Washington University School of Medicine in St Louis
  • 5:35 PM - 5:45 PM ET
    153 - Assessing Atrophy and Neurocognitive Decline in Hippocampal Subfields after Fractionated Brain Radiation Therapy
    Location: Room 147
    Presenter: Hieu Nguyen, BS – UCSD School of Medicine
  • 5:45 PM - 5:55 PM ET
    Discussant
    Location: Room 147
    Discussant: Kristin Redmond, MD, MPH – Johns Hopkins University
  • 4:45 PM - 4:55 PM ET
    154 - A Randomized Controlled Crossover Trial to Evaluate the Efficacy of AI-Assisted Heart Contouring
    Location: Room 207 B
    Presenter: Danielle Bitterman, MD – Brigham and Women's Hospital
  • 4:55 PM - 5:05 PM ET
    155 - Novel Statistical-AI Method to Automate Discovery of Predictive Factors and Thresholds for 3 Year Survival, Dysphagia and Xerostomia for Patients with Head and Neck Cancers
    Location: Room 207 B
    Presenter: Charles Mayo, PhD, FASTRO, FAAPM – University of Michigan
  • 5:05 PM - 5:15 PM ET
    156 - The Fragility of Phase III Trials in Oncology
    Location: Room 207 B
    Presenter: Yufei Liu, MD, PhD – City of Hope National Medical Center
  • 5:15 PM - 5:25 PM ET
    157 - I-SABR-SELECT: A Radiomics-Based Model for Personalized Immunotherapy for Early-Stage Non-Small Cell Lung Cancer
    Location: Room 207 B
    Presenter: Maliazurina Saad, PhD – MD Anderson Cancer Center
  • 5:25 PM - 5:35 PM ET
    158 - Longitudinal CT Feature-Based Model for Predicting Local Recurrence Free Survival in Esophageal Cancer Patients Treated with Definitive Chemoradiotherapy: A Multicenter Study
    Location: Room 207 B
    Presenter: Zhi Yang, MD
  • 5:35 PM - 5:45 PM ET
    159 - Explainable MRI-Based Deep Learning Model for Predicting EGFR Mutation in NSCLC Brain Metastases: Advancing Clinical Prognosis and Oncological Treatment Decisions
    Location: Room 207 B
    Presenter: Che-yu Hsu, MD, PhD, MS – National Taiwan University Hospital
  • 4:45 PM - 4:55 PM ET
    142 - A Phase II Trial of Camrelizumab in Combination with Concurrent Chemoradiotherapy as First-Line Treatment for Betel Nut-Related Locally Advanced Oral Squamous Cell Carcinoma
    Location: Room 152
    Presenter: Feng Liu, MD – Hunan Cancer Hospital
  • 4:55 PM - 5:05 PM ET
    143 - Contralateral Neck Recurrence Rates in Head and Neck Carcinomas after Primary Surgery, Bilateral Neck Dissection, a Pathologically Negative Contralateral Neck, and Adjuvant Ipsilateral Neck Radiation
    Location: Room 152
    Presenter: Kendall Kiser, MD, MS – Washington University/B-JH/SLCH Consortium
  • 5:05 PM - 5:15 PM ET
    144 - Phase II Trial of Proton Re-Irradiation+/-Chemotherapy in Previously Irradiated Recurrent Head/Neck Cancer
    Location: Room 152
    Presenter: Nancy Lee, MD, FASTRO – Memorial Sloan Kettering Cancer Center
  • 5:15 PM - 5:25 PM ET
    145 - Acupuncture for (Chemo)Radiotherapy - Related Dysphagia in Patients with Head and Neck Squamous Cell Carcinoma (HNSCC): A Randomized Phase 2 Study
    Location: Room 152
    Presenter: Pierluigi Bonomo, MD – Azienda Ospedaliera Universitaria Careggi
  • 5:25 PM - 5:35 PM ET
    146 - Opioid Therapy vs. Multimodal Analgesia in Head and Neck Cancer (OPTIMAL-HN): Results of a Randomized Clinical Trial
    Location: Room 152
    Presenter: Sondos Zayed, MD, MPH, FRCPC – University of Ottawa at The Ottawa Hospital
  • 5:35 PM - 5:45 PM ET
    147 - Long Term Effects of Cognitive Behavioral Therapy on Late Toxicities, Depressive and Anxiety Symptoms in Patients with Locoregional Advanced Nasopharyngeal Carcinoma Undergoing Chemoradiotherapy: A Ra
    Location: Room 152
    Presenter: Feng Liu, MD – Hunan Cancer Hospital
  • 5:45 PM - 5:55 PM ET
    Discussant
    Location: Room 152
    Discussant: Christina Henson, MD – University of Oklahoma Health Sciences Center